✦ LIBER ✦

Current Studies with PTK787, an Oral Inhibitor of Vascular Endothelial Growth Factor in Colorectal Cancer

✍ Scribed by Jennifer Klem; Edward Chu; Vinay K. Jain

Book ID: 119616892
Publisher: CIG Media Group, LP.
Year: 2003
Tongue: English
Weight: 104 KB
Volume: 3
Category: Article
ISSN: 1533-0028
DOI: 10.1016/s1533-0028(11)70081-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase III Study of First-Line Oxaliplatin-Based Chemotherapy Plus PTK787/ZK 222584, an Oral Vascular Endothelial Growth Factor Receptor Inhibitor, in Patients With Metastatic Colorectal Adenocarcinoma

✍ Hecht, J. R.; Trarbach, T.; Hainsworth, J. D.; Major, P.; Jager, E.; Wolff, R. A 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 175 KB

Phase I dose escalation, pharmacokinetic

Phase I dose escalation, pharmacokinetic (pk) study of a novel vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK)

✍ Drevs, J.; Mross, K.; Reusch, P.; Peng, B.; Ball, H.; Henry, A.; Laurent, D.; Du 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 163 KB

A phase I study of the oral vascular end

A phase I study of the oral vascular endothelial growth factor (VEGF) receptor tyrosine kinase inhibitor PTK787/ZK 222584 on a twice daily schedule in patients with advanced cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase I pharmacokinetic study of the vas

Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma

✍ David A. Reardon; Merrill J. Egorin; Annick Desjardins; James J. Vredenburgh; Ja 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 297 KB 👁 1 views

Biomarkers for assessment of pharmacolog

Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases

✍ Lucy Lee; Sunil Sharma; Bruno Morgan; Peter Allegrini; Christian Schnell; Josef 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 427 KB

PTK787/ZK 222584, a small molecule tyros

PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia

✍ Francis J. Giles; Alan F. List; Michael Carroll; Jorge E. Cortes; Joyce Valickas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB